Polymorphism in estrogen receptor alpha linked to back pain

Polymorphism in estrogen receptor α linked to back pain
For women with degenerative spondylolisthesis, polymorphisms in the estrogen receptor α (ERα) are associated with back pain intensity, according to a study published in the April issue of the Journal of Spinal Disorders and Techniques.

(HealthDay)—For women with degenerative spondylolisthesis (DS), polymorphisms in the estrogen receptor α (ERα) are associated with back pain intensity, according to a study published in the April issue of the Journal of Spinal Disorders and Techniques.

Hyoung Lok Roh, M.D., from Pusan National University School of Medicine in the Republic of Korea, and colleagues examined the correlation between polymorphisms in the ERα and pain intensity in female DS patients. Data were collected for 192 patients with DS for PvuII and XbaI polymorphisms, , pain intensity at the leg and lower back, and radiological and anthropometric findings.

The researchers found that the XbaI polymorphism was significantly correlated with the visual analog scale score of back pain, with the visual analog scale significantly higher in patients with GG genotype compared with the AG or AA genotypes. In haplotype analyses of the PvuII and XbaI polymorphisms, the presence of the CG haplotype correlated with the intensity of back pain.

"We found ERα gene polymorphism using XbaI to be associated with back in DS patients," the authors write. "However, further studies on a larger number of subjects will be needed."

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Back pain intensity most influential in fusion decision

date Jan 24, 2013

(HealthDay)—Patients seeing a spine surgeon are most influenced by low back pain intensity when considering whether to proceed with spinal fusion surgery, according to a study published in the Jan. 15 issue ...

Recommended for you

Score IDs patients with upper extremity DVT at low risk

date 15 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

date May 29, 2015

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date May 29, 2015

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

patnclaire
Apr 11, 2013
Dear Editors,
Thank you for including the caveat
Full Text (subscription or payment may be required)
Please put this on ALL physorg.com postings that require it. I spend a lot of time going to the sites only to be disappointed that, as a have-not, I cannot access the information. So much for that political tennent in academia for lowering the barrier between haves and havenots.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.